Proteomics Helps in Detecting Breast Cancer Proteins
News Sep 12, 2005
Scripps Research Institute Professor Benjamin Cravatt has reported the latest results of a "proteomics" method at the 230th national meeting of the American Chemical Society in Washington, D.C.
Cravatt and his colleagues looked at dozens of samples of human tumors from breast cancer patients, and then analyzed them with proteomics, the study of the expression, location, concentration, and activity of specific proteins.
The scientists were able to detect human proteins that may be associated with breast cancer—including some that have never before been associated with the disease.
Scientists claim that, these proteins can then potentially be used as markers for detection or prevention or as targets for the design of drugs to treat the disease.
Cravatt, a professor in the Department of Cell Biology and The Skaggs Institute for Chemical Biology at Scripps Research, has been developing an emerging proteomics technology called activity-based protein profiling.
Cravatt combined his activity-based profiling with a highly sensitive proteomics method called multidimensional protein identification technology, or "MudPIT," which relies on mass spectrometry and was originally developed by the laboratory of Scripps Research Professor John Yates, with whom the Cravatt group collaborates.
Basically, the two methods are applied in series—with the activity-based profiling returning pools of proteins and MudPIT then used to analyze these pools of protein in more detail.
"Using these two methods together," says Cravatt, "we have found some known and novel markers of breast cancer pathogenesis."
The combined method, he adds, could potentially be applied to other human diseases to discover markers currently evading detection by other methods.
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
Fructose Formula Poses Risk to Babies With Metabolic DisorderNews
Babies with inherited intolerance of fructose face a risk of acute liver failure if they are fed certain widely available formulas containing fructose, pediatricians and geneticists are warning. Baby formula manufacturers should remove fructose or sucrose, or explicitly label their products to allow parents to avoid those sweeteners if necessary, the doctors say.
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE